Dr. Lal PathLabs Ltd (BOM:539524)
₹ 1,892.7 +4.2 (+0.22%) Market Cap: 316.85 Bil Enterprise Value: 305.86 Bil PE Ratio: 58.28 PB Ratio: 12.57 GF Score: 97/100

Q4 2023 Dr. Lal PathLabs Ltd Earnings Call Transcript

May 11, 2023 / 11:00AM GMT
Release Date Price: ₹953.4 (-2.21%)
Operator

Ladies and gentlemen, good day, and welcome to Dr. Lal PathLabs Q4 FY '23 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Siddharth Rangnekar of CDR India. Thank you, and over to you, sir.

Siddharth Rangnekar
Citigate Dewe Rogerson Communications Private Limited - IR Manager

Thank you, Aman. Good evening, everyone, and welcome to Dr. Lal PathLabs Quarter 4 and FY '23 Earnings Conference Call. Today, we are joined by senior members of the management team, including Honorary Brigadier, Dr. Arvind Lal, Executive Chairman; Dr. Om Prakash Manchanda, Managing Director; Mr. Bharath Uppiliappan, CEO; Mr. Ved Prakash Goel, Group CFO; and Mr. Shankha Banerjee, COO of Suburban and Other Group Companies.

I would like to point out our standard disclaimer here. Some of the statements made on today's call could be forward-looking in nature, and actual results could vary from these forward-looking statements. A detailed disclosure in this regard is available in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot